Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Bioorg Med Chem. 2011 Aug 27;19(21):6474–6482. doi: 10.1016/j.bmc.2011.08.053

Table 4.

Competitive binding of MSH4, CCK4, 12, 13, 14a–14e, 15a–15d, and 17 to MC4R or CCK2R.

Compound MC4R CCK2R

Kia (µM) nb Kia (nM) nb

MSH4 1.3 ± 0.38 5 ndc
17 1.9 ± 0.14 5 nd
14a 7.3 ± 1.1 4 nd
14b 1.6 ± 0.16 4 nd
14c 0.54 ± 0.04 4 nd
14d 0.23 ± 0.02 4 nd
14e 0.17 ± 0.02 4 nd
CCK4 nd 3.1d
12 nd 18 ± 5.7 3
15a nd 67 ± 9.4 3
15b nd 1.5 ± 0.7 3
15c nd 2.0 ± 0.3 3
15d nd 0.80 ± 0.2 3
13 nbe 3 nbe 2
a

Ki values were calculated using the equation Ki = EC50/(1 + ([ligand]/KD)) where [ligand] = 10 nM and KD = 8.3 nM for probe 4 and [ligand] = 2 nM and KD = 34.6 nM for probe 16.

b

The value given represents the average of n independent competition binding experiments, each done in quadruplicate.

c

Not determined.

d

Taken from Reference 30.

e

Compound 13 was unable to inhibit the binding of probe 4 or probe 16 in the concentration range tested (10−5–10−12 M in serine amide).